Targeting neurological abnormalities in lysosomal storage diseases.

van Gool R, Tucker-Bartley A, Yang E, Todd N, Guenther F, Goodlett B, Al-Hertani W, Bodamer OA, Upadhyay J.

Open source

DOI
10.1016/j.tips.2021.11.005
Published
2021-11-27
Container
Trends Pharmacol Sci
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.tips.2021.11.005,
  title = {Targeting neurological abnormalities in lysosomal storage diseases.},
  author = {van Gool R and  Tucker-Bartley A and  Yang E and  Todd N and  Guenther F and  Goodlett B and  Al-Hertani W and  Bodamer OA and  Upadhyay J.},
  year = {2022},
  journal = {Trends Pharmacol Sci},
  doi = {10.1016/j.tips.2021.11.005},
  url = {https://doi.org/10.1016/j.tips.2021.11.005}
}

RIS

TY  - JOUR
TI  - Targeting neurological abnormalities in lysosomal storage diseases.
AU  - van Gool R
AU  -  Tucker-Bartley A
AU  -  Yang E
AU  -  Todd N
AU  -  Guenther F
AU  -  Goodlett B
AU  -  Al-Hertani W
AU  -  Bodamer OA
AU  -  Upadhyay J.
PY  - 2022
JO  - Trends Pharmacol Sci
DO  - 10.1016/j.tips.2021.11.005
UR  - https://doi.org/10.1016/j.tips.2021.11.005
ER  - 

APA

R, V. G., A, T., E, Y., N, T., F, G., B, G., W, A., OA, B., & J., U. (2022). Targeting neurological abnormalities in lysosomal storage diseases.. Trends Pharmacol Sci. https://doi.org/10.1016/j.tips.2021.11.005

Source records